LAURIE MICHLIN: Open Payments
NPI 1518917111 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 73 payments from 18 companies in 2025. Trend: 2023 $1,528 · 2024 $1,389 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $272 |
| AstraZeneca Pharmaceuticals LP | 5 | $171 |
| Novo Nordisk Inc | 6 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $158 |
| Lundbeck LLC | 5 | $91 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Almatica Pharma LLC | 5 | $86 |
| Medtronic, Inc. | 1 | $73 |
| Amgen Inc. | 4 | $63 |
| Lilly USA, LLC | 4 | $63 |
Products named: JARDIANCE, NURTEC ODT, AIRSUPRA, ELIQUIS, Ozempic, LOREEV XR, REXULTI, MAZOR X SYSTEM.
Industry payments across NV — which companies pay providers there.
